Back

Analysis of genes to predict the effects of proprotein convertase subtilisin/kexin type 9-inhibitors and statins

Cardiovascular Research

27 April 2017
Organised by: Logo
Read full article
ESC Journals

Contributors

Ulrich Laufs
Ulrich Laufs

Author

You may be interested in
thumbnail
Congress Presentation
Efficacy and safety of proprotein covertase subtilisin/kexin type 9 inhibitors among patients with acute coronary syndrome: a meta-analysis of randomized controlled trials
27 August 2022
thumbnail
Webinar
Biomarkers of clinical utility in cardiovascular disease
17 December 2024
thumbnail
Congress Presentation
Epigenetic regulation of PCSK9 expression by statins
26 August 2023
thumbnail
Congress Presentation
High-dose statins are associated with increased aortic valve calcium load in patients with severe stenosis
25 April 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources